DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,632,222 | -27.7% | 10,597,781 | +3.5% | 0.01% | -28.6% |
| Q2 2023 | $302,270,428 | +29.7% | 10,242,983 | +1.2% | 0.01% | +16.7% |
| Q1 2023 | $233,130,079 | -15.7% | 10,118,493 | +1.7% | 0.01% | -25.0% |
| Q4 2022 | $276,628,795 | +7.3% | 9,947,098 | +18.4% | 0.01% | 0.0% |
| Q3 2022 | $257,858,000 | +5.5% | 8,402,031 | +1.2% | 0.01% | +14.3% |
| Q2 2022 | $244,342,000 | -6.4% | 8,302,501 | +2.3% | 0.01% | +16.7% |
| Q1 2022 | $260,964,000 | -28.3% | 8,112,030 | -0.6% | 0.01% | -25.0% |
| Q4 2021 | $364,004,000 | -11.7% | 8,161,530 | -0.1% | 0.01% | -20.0% |
| Q3 2021 | $412,101,000 | -31.3% | 8,168,483 | +6.9% | 0.01% | -33.3% |
| Q2 2021 | $599,605,000 | +28.6% | 7,644,130 | -6.4% | 0.02% | +15.4% |
| Q1 2021 | $466,305,000 | -29.8% | 8,166,450 | +3.0% | 0.01% | -31.6% |
| Q4 2020 | $663,803,000 | +176.4% | 7,925,057 | +18.3% | 0.02% | +137.5% |
| Q3 2020 | $240,124,000 | +40.1% | 6,701,740 | -5.4% | 0.01% | +33.3% |
| Q2 2020 | $171,337,000 | +41.6% | 7,085,930 | +2.6% | 0.01% | +20.0% |
| Q1 2020 | $120,965,000 | +11.9% | 6,908,331 | +11.3% | 0.01% | +25.0% |
| Q4 2019 | $108,135,000 | +15.8% | 6,207,542 | +1.8% | 0.00% | +33.3% |
| Q3 2019 | $93,414,000 | -22.6% | 6,097,446 | +4.9% | 0.00% | -40.0% |
| Q2 2019 | $120,642,000 | -21.1% | 5,811,315 | -11.7% | 0.01% | -16.7% |
| Q1 2019 | $152,854,000 | +12.9% | 6,582,849 | +0.4% | 0.01% | 0.0% |
| Q4 2018 | $135,423,000 | +29.0% | 6,554,883 | +35.8% | 0.01% | +50.0% |
| Q3 2018 | $104,954,000 | +117.3% | 4,827,710 | +52.5% | 0.00% | +100.0% |
| Q2 2018 | $48,293,000 | +116.5% | 3,166,726 | +179.5% | 0.00% | +100.0% |
| Q1 2018 | $22,308,000 | +53.9% | 1,132,939 | +22.3% | 0.00% | 0.0% |
| Q4 2017 | $14,494,000 | – | 926,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |